24.400
+6,55%
2026-10-19
Fundamental Analysis
74 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +38.0% | +32.4% | 2 / 3 | -62.2% | +18.95 pp | +8.54 pp | +29.9% | 0.44 | 4.77 | 25,9 | −62,2% | 3,0 | +38,0% | 4.77 | 7.02 | −32,1% |
| Pts | 8 | 4 | 8 | 0 | 12 | 12 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 24.400 (close price on 2026-10-19)EPS (TTM): 5.117
Financial charts
1.Revenue & growth
VND bn25,9Q2/26
1.Revenue & growth
VND bn25,9Q2/26
2.Profit & growth
VND bn2,88Q2/26
3.Profit mix (Penman)
VND bn18,3Q2/26
4.Margins & cost structure
%24.5%Q2/26
5.Returns & cash cycle
% · days22.1%Q2/26
6.Earnings quality & cash
VND bn21,9Q2/26
7.Asset structure
VND bn131Q2/26
8.Funding & debt health
VND bn · times131Q2/26
9.Revenue backlog
VND bn1,95Q2/26
10.Valuation
times · %4,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %890Q2/26
Adjusted EPS growth, latest quarter
30.8%
Average adjusted EPS growth, 3 quarters
30.0%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26